OKYO Pharma to hold advisory board meeting at ASCRS annual event

try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Iran latest: IRGC warns of years-long oil, gas disruption if US crosses red lines Trump’s Iran threat looms large; Broadcom’s Google deal - what’s moving markets Oil hovers below $110 with Trump’s Hormuz deadline edging closer IEA chief says Hormuz blockade worst energy crisis in history (South Africa Philippines Nigeria) OKYO Pharma to hold advisory board meeting at ASCRS annual event By SEC Filings Published 04/07/2026, 07:22 AM OKYO Pharma to hold advisory board meeting at ASCRS annual event 0 OKYO -6.55% OKYO Pharma Ltd (NASDAQ:OKYO) announced Tuesday that it will convene a Scientific Advisory Board meeting with ophthalmology experts during the 2026 American Society of Cataract and Refractive Surgery Annual Meeting in Washington, DC. According to a statement included in a recent SEC filing, the meeting is set to take place alongside the ASCRS conference and will bring together specialists focused on corneal and ocular surface diseases. The primary agenda for the advisory board is to review clinical data for OKYO Pharma’s lead candidate, urcosimod, and to provide strategic guidance for the company’s upcoming clinical program. The company stated that the event will assemble leading experts in the field to assess the progress of urcosimod and discuss potential next steps. No further details regarding the timing of the meeting or specific participants were disclosed in the filing. This information is based on a press release statement included in OKYO Pharma’s SEC filing. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.